Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2023-08-10 Sale | 2023-08-11 7:11 pm | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 231,716 | $12.92 | $2,994,401 | 480,043 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-04-12 Exercise | 2024-04-15 4:24 pm | N/A N/A | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 6,349 | $1.08 | 315,307 (Direct) | View |
2024-04-11 Exercise | 2024-04-15 4:24 pm | N/A N/A | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 5,017 | $0.54 | 315,307 (Direct) | View |
2024-04-11 Exercise | 2024-04-15 4:24 pm | N/A 2031-03-11 | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 11,366 | $0 | 315,307 (Direct) | View |
2024-03-12 Exercise | 2024-03-13 5:35 pm | N/A N/A | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 6,348 | $1.08 | 315,307 (Direct) | View |
2024-03-11 Exercise | 2024-03-13 5:35 pm | N/A N/A | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 5,017 | $0.54 | 315,307 (Direct) | View |
2024-03-11 Exercise | 2024-03-13 5:35 pm | N/A 2031-03-11 | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 11,365 | $0 | 315,307 (Direct) | View |
2024-02-13 Option Award | 2024-02-15 4:26 pm | N/A 2034-02-13 | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 200,000 | $0 | 200,000 (Direct) | View |
2024-02-12 Exercise | 2024-02-13 4:08 pm | N/A N/A | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 6,349 | $1.08 | 315,307 (Direct) | View |
2024-02-12 Exercise | 2024-02-13 4:08 pm | N/A N/A | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 5,017 | $0.54 | 315,307 (Direct) | View |
2024-02-12 Exercise | 2024-02-13 4:08 pm | N/A 2031-03-11 | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 11,366 | $0 | 315,307 (Direct) | View |
2024-01-12 Exercise | 2024-01-12 4:01 pm | N/A N/A | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 6,348 | $1.08 | 315,307 (Direct) | View |
2024-01-11 Exercise | 2024-01-12 4:01 pm | N/A N/A | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 5,017 | $0.54 | 315,307 (Direct) | View |
2024-01-11 Exercise | 2024-01-12 4:01 pm | N/A 2031-03-11 | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 11,365 | $0 | 315,307 (Direct) | View |
2023-12-11 Exercise | 2023-12-12 5:08 pm | N/A N/A | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 5,018 | $0.54 | 85,293 (Direct) | View |
2023-12-11 Exercise | 2023-12-12 5:08 pm | N/A 2031-03-11 | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 5,018 | $0 | 85,293 (Direct) | View |
2023-11-13 Exercise | 2023-11-14 6:18 pm | N/A N/A | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 5,017 | $0.54 | 85,293 (Direct) | View |
2023-11-13 Exercise | 2023-11-14 6:18 pm | N/A 2031-03-11 | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 5,017 | $0 | 85,293 (Direct) | View |
2023-11-03 Exercise | 2023-11-07 5:15 pm | N/A N/A | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 10,034 | $0.54 | 85,293 (Direct) | View |
2023-11-03 Exercise | 2023-11-07 5:15 pm | N/A 2031-03-11 | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 10,034 | $0 | 85,293 (Direct) | View |
2023-08-11 Exercise | 2023-08-11 7:11 pm | N/A N/A | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 76,182 | $1.08 | 480,043 (Direct) | View |
2023-08-10 Exercise | 2023-08-11 7:11 pm | N/A N/A | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 155,534 | $0.54 | 480,043 (Direct) | View |
2023-08-10 Exercise | 2023-08-11 7:11 pm | N/A 2031-03-11 | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 231,716 | $0 | 480,043 (Direct) | View |
2023-03-17 Option Award | 2023-03-21 6:48 pm | N/A 2033-03-17 | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 20,000 | $0 | 20,000 (Direct) | View |
2023-02-09 Option Award | 2023-02-13 9:01 pm | N/A 2033-02-09 | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 104,186 | $0 | 104,186 (Direct) | View |
Ownership | 2023-02-09 7:53 pm | N/A 2031-03-11 | Mineralys Therapeutics Inc. | MLYS | Rodman David Malcom Chief Medical Officer | 0 | $0 | 545,557 (Direct) | View |